- ATAI Life Sciences NV Announces Strategic Investment in Beckley Psytech Ltd Call TranscriptJan 04, 2024
- Q3 2022 ATAI Life Sciences NV Earnings Presentation TranscriptNov 10, 2022
- ATAI Life Sciences NV R&D Investor Day TranscriptOct 25, 2022
- ATAI Life Sciences NV at Citi BioPharma Conference TranscriptSep 07, 2022
- Q2 2022 ATAI Life Sciences NV Earnings Presentation TranscriptAug 15, 2022
- ATAI Life Sciences NV at Citi Biopharma Co-Panel Day (Virtual) TranscriptMay 18, 2022
- Q1 2022 ATAI Life Sciences NV Earnings Call TranscriptMay 16, 2022$4.04 (+10.99%)Earnings
- Q4 2021 ATAI Life Sciences NV Earnings Call TranscriptMar 30, 2022$5.34 (-1.48%)Earnings
- ATAI Life Sciences NV at Citi Winter Biotech Virtual Bus Tour TranscriptMar 22, 2022
- Atai Life Sciences N.V. - Special Call TranscriptJan 18, 2022
- Q3 2021 ATAI Life Sciences NV Earnings Call TranscriptNov 15, 2021$12.85 (-13.87%)Earnings
- ATAI Life Sciences NV at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- ATAI Life Sciences NV at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
ATAI Life Sciences NV at Citi BioPharma Conference (Virtual) Transcript
All right. So good afternoon, everybody, and thanks for attending Citi's 16th Annual Biopharma Conference. I'm Neena Bitritto-Garg, one of the biotech analysts here at Citi.
For our next session, I'm really happy to be joined by the CEOs of 2 companies addressing mental health conditions through studying psychedelic drugs, including George Goldsmith from COMPASS Pathways and Florian Brand from Atai Life Sciences. So over the next 45 minutes or so, we're going to talk about the potential for psychedelic medicines and mental health conditions as well as some specifics of each company's programs.
But before we do get into the discussion, if anybody listening has questions that you want me to ask, feel free to either e-mail me directly or submit your questions through the web portal, and then I can incorporate them if there is time.
So now I want to just turn it over to Florian and George to each give kind of a quick introduction. I don't know if we want to go alphabetically for anyone
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)